Titre : Racépinéfrine

Racépinéfrine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Network Meta-Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Racépinéfrine : Questions médicales les plus fréquentes", "headline": "Racépinéfrine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Racépinéfrine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-21", "dateModified": "2025-03-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Racépinéfrine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Épinéphrine", "url": "https://questionsmedicales.fr/mesh/D004837", "about": { "@type": "MedicalCondition", "name": "Épinéphrine", "code": { "@type": "MedicalCode", "code": "D004837", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.657.166.175.461" } } }, "about": { "@type": "MedicalCondition", "name": "Racépinéfrine", "alternateName": "Racepinephrine", "code": { "@type": "MedicalCode", "code": "D064705", "codingSystem": "MeSH" } }, "citation": [ { "@type": "ScholarlyArticle", "name": "Tocolytics for delaying preterm birth: a network meta-analysis (0924).", "datePublished": "2022-08-10", "url": "https://questionsmedicales.fr/article/35947046", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD014978.pub2" } }, { "@type": "ScholarlyArticle", "name": "Bayesian unanchored additive models for component network meta-analysis.", "datePublished": "2022-07-17", "url": "https://questionsmedicales.fr/article/35844085", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/sim.9520" } }, { "@type": "ScholarlyArticle", "name": "Pharmacological treatments in panic disorder in adults: a network meta-analysis.", "datePublished": "2023-11-28", "url": "https://questionsmedicales.fr/article/38014714", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD012729.pub3" } }, { "@type": "ScholarlyArticle", "name": "Thresholds for surfactant use in preterm neonates: a network meta-analysis.", "datePublished": "2022-12-09", "url": "https://questionsmedicales.fr/article/36600484", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/archdischild-2022-324184" } }, { "@type": "ScholarlyArticle", "name": "Cardiotoxicity of immune checkpoint inhibitors: A frequency network meta-analysis.", "datePublished": "2022-09-14", "url": "https://questionsmedicales.fr/article/36189211", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.1006860" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Phénols", "item": "https://questionsmedicales.fr/mesh/D010636" }, { "@type": "ListItem", "position": 8, "name": "Catéchols", "item": "https://questionsmedicales.fr/mesh/D002396" }, { "@type": "ListItem", "position": 9, "name": "Catécholamines", "item": "https://questionsmedicales.fr/mesh/D002395" }, { "@type": "ListItem", "position": 10, "name": "Épinéphrine", "item": "https://questionsmedicales.fr/mesh/D004837" }, { "@type": "ListItem", "position": 11, "name": "Racépinéfrine", "item": "https://questionsmedicales.fr/mesh/D064705" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Racépinéfrine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Racépinéfrine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Racépinéfrine", "description": "Comment diagnostiquer une crise d'asthme ?\nQuels tests sont utilisés pour évaluer l'efficacité de la racépinéfrine ?\nQuels symptômes indiquent une obstruction bronchique ?\nComment différencier l'asthme de la BPCO ?\nQuels signes cliniques nécessitent une intervention immédiate ?", "url": "https://questionsmedicales.fr/mesh/D064705?mesh_terms=Network+Meta-Analysis&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Racépinéfrine", "description": "Quels sont les effets secondaires courants de la racépinéfrine ?\nComment reconnaître une réaction allergique à la racépinéfrine ?\nQuels symptômes indiquent une surdose de racépinéfrine ?\nQuels symptômes peuvent nécessiter un changement de traitement ?\nQuels signes indiquent une amélioration après traitement ?", "url": "https://questionsmedicales.fr/mesh/D064705?mesh_terms=Network+Meta-Analysis&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Racépinéfrine", "description": "Comment prévenir les crises d'asthme ?\nQuels conseils donner aux patients asthmatiques ?\nComment gérer les allergies pour prévenir l'asthme ?\nQuel rôle joue l'exercice dans la prévention de l'asthme ?\nComment la vaccination peut-elle aider les asthmatiques ?", "url": "https://questionsmedicales.fr/mesh/D064705?mesh_terms=Network+Meta-Analysis&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Racépinéfrine", "description": "Comment la racépinéfrine est-elle administrée ?\nQuelle est la posologie recommandée pour les adultes ?\nQuels autres traitements peuvent être combinés avec la racépinéfrine ?\nQuand faut-il éviter d'utiliser la racépinéfrine ?\nComment évaluer l'efficacité du traitement par racépinéfrine ?", "url": "https://questionsmedicales.fr/mesh/D064705?mesh_terms=Network+Meta-Analysis&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Racépinéfrine", "description": "Quelles sont les complications possibles de l'asthme non contrôlé ?\nComment la racépinéfrine peut-elle affecter le cœur ?\nQuels risques sont associés à une surutilisation de la racépinéfrine ?\nQuelles sont les conséquences d'une mauvaise utilisation des inhalateurs ?\nQuels sont les risques d'une dépendance aux bronchodilatateurs ?", "url": "https://questionsmedicales.fr/mesh/D064705?mesh_terms=Network+Meta-Analysis&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Racépinéfrine", "description": "Quels facteurs augmentent le risque d'asthme ?\nComment le tabagisme influence-t-il l'asthme ?\nQuel rôle joue l'obésité dans l'asthme ?\nQuels environnements sont à risque pour les asthmatiques ?\nComment le stress affecte-t-il l'asthme ?", "url": "https://questionsmedicales.fr/mesh/D064705?mesh_terms=Network+Meta-Analysis&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une crise d'asthme ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur les antécédents médicaux, l'examen physique et des tests de fonction pulmonaire." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'efficacité de la racépinéfrine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de spirométrie mesurent le volume d'air inhalé et expiré pour évaluer la fonction pulmonaire." } }, { "@type": "Question", "name": "Quels symptômes indiquent une obstruction bronchique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent la toux, la respiration sifflante, et l'essoufflement." } }, { "@type": "Question", "name": "Comment différencier l'asthme de la BPCO ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'asthme est réversible avec des bronchodilatateurs, tandis que la BPCO est généralement irréversible." } }, { "@type": "Question", "name": "Quels signes cliniques nécessitent une intervention immédiate ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une détresse respiratoire sévère, cyanose ou incapacité à parler sont des signes d'urgence." } }, { "@type": "Question", "name": "Quels sont les effets secondaires courants de la racépinéfrine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent tremblements, palpitations et nervosité." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique à la racépinéfrine ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent éruption cutanée, démangeaisons, et gonflement du visage ou de la gorge." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surdose de racépinéfrine ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent tachycardie, hypertension et agitation excessive." } }, { "@type": "Question", "name": "Quels symptômes peuvent nécessiter un changement de traitement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une aggravation des symptômes respiratoires malgré le traitement peut nécessiter une réévaluation." } }, { "@type": "Question", "name": "Quels signes indiquent une amélioration après traitement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une diminution de la toux, une respiration plus facile et une meilleure capacité d'exercice sont des signes d'amélioration." } }, { "@type": "Question", "name": "Comment prévenir les crises d'asthme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les déclencheurs connus, suivre un plan de traitement et utiliser des médicaments préventifs." } }, { "@type": "Question", "name": "Quels conseils donner aux patients asthmatiques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éduquer sur l'utilisation correcte des inhalateurs et l'importance de la surveillance des symptômes." } }, { "@type": "Question", "name": "Comment gérer les allergies pour prévenir l'asthme ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les allergènes, utiliser des antihistaminiques et maintenir un environnement propre." } }, { "@type": "Question", "name": "Quel rôle joue l'exercice dans la prévention de l'asthme ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier peut améliorer la fonction pulmonaire, mais doit être adapté aux capacités individuelles." } }, { "@type": "Question", "name": "Comment la vaccination peut-elle aider les asthmatiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations contre la grippe et le pneumocoque peuvent réduire le risque d'infections respiratoires." } }, { "@type": "Question", "name": "Comment la racépinéfrine est-elle administrée ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elle est généralement administrée par inhalation via un nébuliseur ou un inhalateur." } }, { "@type": "Question", "name": "Quelle est la posologie recommandée pour les adultes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La posologie varie, mais elle est souvent de 0,5 à 1,0 mg par inhalation, selon les besoins." } }, { "@type": "Question", "name": "Quels autres traitements peuvent être combinés avec la racépinéfrine ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des corticostéroïdes inhalés peuvent être utilisés en complément pour un meilleur contrôle de l'asthme." } }, { "@type": "Question", "name": "Quand faut-il éviter d'utiliser la racépinéfrine ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elle doit être évitée en cas d'hypersensibilité connue ou de maladies cardiaques sévères." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité du traitement par racépinéfrine ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité peut être évaluée par l'amélioration des symptômes et des tests de fonction pulmonaire." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de l'asthme non contrôlé ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des crises d'asthme sévères, des infections pulmonaires et des hospitalisations." } }, { "@type": "Question", "name": "Comment la racépinéfrine peut-elle affecter le cœur ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer des palpitations et une augmentation de la fréquence cardiaque chez certains patients." } }, { "@type": "Question", "name": "Quels risques sont associés à une surutilisation de la racépinéfrine ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une surutilisation peut entraîner une tachyphylaxie, réduisant son efficacité et augmentant les effets secondaires." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une mauvaise utilisation des inhalateurs ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise utilisation peut entraîner un contrôle insuffisant des symptômes et des exacerbations fréquentes." } }, { "@type": "Question", "name": "Quels sont les risques d'une dépendance aux bronchodilatateurs ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une dépendance peut conduire à une mauvaise gestion de l'asthme et à des crises plus fréquentes." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'asthme ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, l'exposition à des allergènes et la pollution de l'air sont des facteurs de risque." } }, { "@type": "Question", "name": "Comment le tabagisme influence-t-il l'asthme ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme aggrave les symptômes de l'asthme et augmente le risque de complications." } }, { "@type": "Question", "name": "Quel rôle joue l'obésité dans l'asthme ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité peut aggraver l'asthme en augmentant l'inflammation et en réduisant la fonction pulmonaire." } }, { "@type": "Question", "name": "Quels environnements sont à risque pour les asthmatiques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les environnements avec des allergènes élevés, comme les moisissures et les pollens, sont à risque." } }, { "@type": "Question", "name": "Comment le stress affecte-t-il l'asthme ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut déclencher des crises d'asthme en augmentant l'inflammation et la réactivité bronchique." } } ] } ] }

Sources (10000 au total)

Tocolytics for delaying preterm birth: a network meta-analysis (0924).

Preterm birth is the leading cause of death in newborns and children. Tocolytic drugs aim to delay preterm birth by suppressing uterine contractions to allow time for administration of corticosteroids... To estimate relative effectiveness and safety profiles for different classes of tocolytic drugs for delaying preterm birth, and provide rankings of the available drugs.... We searched Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials.gov (21 April 2021) and reference lists of retrieved studies.... We included all randomised controlled trials assessing effectiveness or adverse effects of tocolytic drugs for delaying preterm birth. We excluded quasi- and non-randomised trials. We evaluated all st... At least two review authors independently assessed the trials for inclusion and risk of bias, and extracted data. We performed pairwise and network meta-analyses, to determine the relative effects and... This network meta-analysis includes 122 trials (13,697 women) involving six tocolytic classes, combinations of tocolytics, and placebo or no treatment. Most trials included women with threatened prete... Compared with placebo or no tocolytic treatment, all tocolytic drug classes that we assessed (betamimetics, calcium channel blockers, magnesium sulphate, oxytocin receptor antagonists, nitric oxide do...

Pharmacological treatments in panic disorder in adults: a network meta-analysis.

A panic attack is a discrete period of fear or anxiety that has a rapid onset and reaches a peak within 10 minutes. The main symptoms involve bodily systems, such as racing heart, chest pain, sweating... To compare, via network meta-analysis, individual drugs (antidepressants and benzodiazepines) or placebo in terms of efficacy and acceptability in the acute treatment of panic disorder, with or withou... We searched the Cochrane Common Mental Disorders Specialised Register, CENTRAL, CDSR, MEDLINE, Ovid Embase and PsycINFO to 26 May 2022.... We included randomised controlled trials (RCTs) of people aged 18 years or older of either sex and any ethnicity with clinically diagnosed panic disorder, with or without agoraphobia. We included tria... Two authors independently screened titles/abstracts and full texts, extracted data and assessed risk of bias. We analysed dichotomous data and continuous data as risk ratios (RRs), mean differences (M... Overall, we included 70 trials in this review. Sample sizes ranged between 5 and 445 participants in each arm, and the total sample size per study ranged from 10 to 1168. Thirty-five studies included ... In terms of efficacy, SSRIs, SNRIs (venlafaxine), TCAs, MAOIs and BDZs may be effective, with little difference between classes. However, it is important to note that the reliability of these findings...

Thresholds for surfactant use in preterm neonates: a network meta-analysis.

To perform a network meta-analysis of randomised controlled trials of different surfactant treatment strategies for respiratory distress syndrome (RDS) to assess if a certain fraction of inspired oxyg... Systematic review and network meta-analysis using Bayesian analysis of randomised trials of prophylactic versus selective surfactant for RDS.... Cochrane Central Register of Controlled Trials, MEDLINE, Embase and Science Citation Index Expanded.... Randomised trials including infants under 32 weeks of gestational age.... Intratracheal surfactant, irrespective of type or dose.... Our primary outcome was neonatal mortality, compared between groups treated with selective surfactant therapy at different thresholds of FiO... Of 4643 identified references, 14 studies involving 5298 participants were included. We found no statistically significant differences between 30%, 40% and 50% FiO... Our results do not show a clear benefit of surfactant treatment at any threshold of FiO... CRD42020166620....

Common bile duct stones management: A network meta-analysis.

Timely management is critical for treating symptomatic common bile duct (CBD) stones; however, a single optimal management strategy has yet to be defined in the acute care setting. Consequently, this ... PubMed, SCOPUS, MEDLINE, Embase, and Cochrane Central Register of Controlled Trials were methodically queried for articles from 2010 to 2021. The search terms were a combination of medical subject hea... A total of 16 studies (8,644 participants) addressing the LOS and 41 studies (19,756 participants) addressing postprocedural complications were included in the analysis. The one-stage approaches were ... This network meta-analysis suggests that both laparoscopic CBD exploration and intraoperative ERCP have equally good outcomes and provide a preferable single-anesthesia patient pathway with a shorter ... Systematic Review/Meta Analysis; Level III....

Immunomodulators and immunosuppressants for progressive multiple sclerosis: a network meta-analysis.

In recent years a broader range of immunomodulatory and immunosuppressive treatment options have emerged for people with progressive forms of multiple sclerosis (PMS). While consensus supports these o... To compare through network meta-analysis the efficacy and safety of alemtuzumab, azathioprine, cladribine, cyclophosphamide, daclizumab, dimethylfumarate, diroximel fumarate, fingolimod, fludarabine, ... We searched CENTRAL, MEDLINE, and Embase up to August 2022, as well as ClinicalTrials.gov and the WHO ICTRP.... Randomised controlled trials (RCTs) that studied one or more treatments as monotherapy, compared to placebo or to another active agent, for use in adults with PMS.... Two review authors independently selected studies and extracted data. We performed data synthesis by pair-wise and network meta-analysis. We assessed the certainty of the body of evidence according to... We included 23 studies involving a total of 10,167 participants. The most frequent (39% of studies) reason for a rating of high risk of bias was sponsor role in study authorship and data management an... The number of people with PMS with relapses is probably slightly reduced with rituximab at two years, and interferon beta-1b at three years, compared to placebo. Both drugs are also probably associate...

Moist dressings in the treatment of pressure injuries: A network meta-analysis.

The aim of this network meta-analysis is to analyze the difference in therapeutic effects between moist dressings and traditional dressings in the treatment of pressure injury (PI), explore the healin... The incidence of pressure injury is high and the burden of disease is high, but there is no consensus on how to choose moist dressing treatment.... A systematic review with network meta-analysis was performed.... We searched the Chinese Biomedicine Literature Database and China National Knowledge Infrastructure, Wanfang Database, VIP database, PubMed, Web of Science, EMBASE.com, CENTRAL (Cochrane Central Regis... R studio software and Stata 16.0 software were used to compare different moist dressings and traditional dressings.... 41 RCTs of moist dressings in the treatment of PI were included. A total of seven kinds of moist dressings, Vaseline gauze and traditional gauze dressing were involved. All RCTs were at a medium to hi... The effect of moist dressings in treating PI is more advantageous than traditional dressings. However, in terms of direct cost and the number of dressings changes, more research is needed to improve t... This study is a network meta-analysis, which does not require the participation of patients and the public....